Stay updated on Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial
Sign up to get notified when there's something new on the Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial page.

Latest updates to the Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial page
- Check4 days agoChange DetectedThe footer’s site revision label changed from v3.7.2 to v3.8.0. The study record area still displays a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appeared above the page, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check25 days agoChange DetectedThe site revision shown in the footer changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the usual study details with a generic error screen. This indicates restricted access to the page and redirects to a basic home view.SummaryDifference16%

- Check53 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page shows a new revision tag: v3.6.6, replacing the previous v3.6.5. This indicates a small update to the page’s versioning rather than a change to the study data.SummaryDifference0.0%

Stay in the know with updates to Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial page.